background
kawasaki
diseas
kd
selflimit
acut
system
vascul
occur
mainli
infant
young
children
year
old
although
use
acetylsalicyl
acid
aa
combin
intraven
immunoglobulin
ivig
remain
standard
therapi
kd
etiolog
genet
suscept
gene
pathogen
factor
kd
still
unelucid
purpos
current
obstacl
treatment
kd
includ
lack
standard
clinic
genet
marker
earli
diagnosi
possibl
sever
side
effect
aa
rey
syndrom
refractori
kd
case
resist
ivig
therapi
therefor
review
focus
introduc
current
advanc
identif
genet
suscept
gene
environment
factor
diagnost
marker
adjuv
pharmacolog
intervent
kd
result
overal
updat
develop
kd
differ
aspect
current
bioinformat
data
suggest
possibl
pathogen
factor
diagnost
marker
kd
besid
list
herbal
medicin
may
work
adjunct
therapi
kd
via
target
differ
propos
molecular
target
kd
also
summar
conclus
aid
modern
pharmacolog
research
technolog
anticip
novel
therapeut
remedi
especi
activ
herbal
chemic
target
precis
clinic
marker
kd
could
develop
accur
diagnosi
treatment
diseas
denbi
et
al
besid
kd
report
affect
mani
differ
organ
system
includ
blood
vessel
mucou
membran
skin
lymph
node
kuwabara
et
al
case
occur
children
year
old
survey
indic
cal
caus
kd
gradual
replac
rheumat
common
acquir
heart
diseas
childhood
develop
countri
dimitriad
et
al
although
caus
kd
remain
unclear
effect
ivig
intervent
within
therapeut
window
lower
rate
cal
format
less
kuwabara
et
al
suspect
case
report
kawasaki
kd
identifi
acut
pediatr
system
vascul
clinic
symptom
sustain
fever
oral
mucos
lesion
pleural
rash
swollen
cervic
lymph
node
conjunctiv
hyperemia
sever
swell
hand
foot
skin
peel
fingertip
one
seriou
sequela
kd
inflamm
heart
arteri
lead
format
aneurysm
coronari
arteri
lesion
cal
noteworthi
recent
year
subtyp
kd
kd
shock
syndrom
also
report
sever
correl
coronari
arteri
abnorm
ivig
resist
gamezgonzalez
et
al
therefor
earli
diagnosi
treatment
kd
particularli
import
although
recent
advanc
understand
kd
symptom
treatment
substanti
reduc
rate
complic
diseas
consider
effort
requir
character
caus
caus
genet
serolog
marker
correl
pathogenesi
diagnosi
intervent
kd
although
increas
trend
kd
incid
risk
factor
respons
current
increas
case
remain
unclear
singh
et
al
japan
korea
taiwan
region
list
highest
incid
rate
kd
singh
et
al
japan
accord
nationwid
survey
conduct
estim
incid
rate
kd
case
per
children
year
old
burn
et
al
accord
kd
nation
epidemiolog
survey
japan
averag
number
new
case
year
total
number
kd
case
reach
male
femal
japan
incid
kd
korea
per
children
year
old
kim
et
al
although
nation
occurr
kd
report
past
year
season
peak
kd
incid
also
report
mani
geograph
region
burn
et
al
exampl
peak
kd
incid
occur
januari
juli
japan
mainland
china
taiwan
peak
kd
incid
reach
decemb
januari
june
juli
usa
australia
canada
europ
higher
kd
incid
rate
observ
winter
month
ha
et
al
singh
et
al
signific
season
variat
kd
report
korea
rhim
et
al
rhim
et
al
overal
higher
incid
rate
kd
male
femal
maletofemal
ratio
japan
korea
taiwan
respect
ha
et
al
lue
et
al
singh
et
al
accord
american
heart
associ
aha
diagnost
guidelin
intern
symposium
diagnost
guidelin
classic
clinic
symptom
criteria
diagnosi
kd
list
ayusawa
et
al
saguil
et
al
gener
principl
continu
high
fever
last
least
day
respons
antibiot
antipyret
develop
least
list
classic
diagnost
symptom
includ
polymorph
rash
conjunct
cervic
lymphadenopathi
chang
oral
extrem
could
diagnos
kd
kuo
et
al
addit
assess
clinic
symptom
laboratori
diagnosi
cardiovascular
damag
chest
xray
find
electrocardiogram
chang
auscult
aneurysm
peripher
arteri
coronari
echocardiographi
angina
pectori
myocardi
infarct
also
import
supplement
diagnosi
kd
ayusawa
et
al
saguil
et
al
supplementari
diagnost
refer
platelet
count
also
appli
diagnosi
suspect
case
kd
ruan
et
al
fact
diagnost
guidelin
kd
revis
time
japan
major
chang
list
tabl
diagnost
guidelin
th
revis
commonli
use
diagnosi
kd
japan
current
diagnost
guidelin
set
aha
diagnost
criteria
us
revis
time
sinc
major
chang
list
tabl
b
besid
korea
china
europ
countri
adopt
aha
guidelin
refer
diagnosi
kd
although
standard
diagnost
criteria
compil
due
variabl
clinic
symptom
differ
case
discrep
interpret
clinic
sign
symptom
led
undiagnos
unreport
case
kd
ayusawa
et
al
daniel
et
al
howev
recent
report
suggest
evalu
system
inflammatori
paramet
creactiv
protein
crp
neutrophil
differenti
albumin
hemoglobin
earli
phase
acut
kd
critic
earli
diagnosi
kd
seo
et
al
consist
addit
studi
suggest
increas
level
immunoglobulin
platelet
recoveri
phase
kd
may
indic
degre
system
inflamm
acut
kd
although
therapeut
strategi
differ
type
kd
remain
case
kd
classifi
stereotyp
nonstereotyp
incomplet
type
accord
clinic
symptom
patient
japan
accord
diagnost
guidelin
th
revis
kd
patient
divid
differ
type
complet
kd
least
develop
classic
kd
symptom
includ
fever
persist
day
inclus
case
fever
subsid
th
day
respons
therapi
ii
bilater
conjunctiv
congest
iii
chang
lip
oral
caviti
redden
lip
strawberri
tongu
diffus
inject
oral
pharyng
mucosa
iv
polymorph
exanthema
v
chang
peripher
extrem
progress
redden
palm
sole
edema
convalesc
stage
membran
desquam
fingertip
vi
acut
nonpurul
cervic
lymphadenopathi
incomplet
kd
sustain
fever
day
accompani
classic
kd
symptom
togeth
diagnosi
base
echocardiographi
coronari
angiographi
rule
possibl
diseas
atyp
kd
accord
doctor
evalu
patient
classic
kd
symptom
accompani
acut
diarrhea
upper
airway
obstruct
proteinuria
nephriti
shock
massiv
lymphadenopathi
mening
blind
intermitt
deaf
clinic
symptom
ayusawa
et
al
base
statist
nation
epidemiolog
survey
kd
japan
percentag
stereotyp
nonstereotyp
kd
respect
case
refer
incomplet
type
japan
noteworthi
increas
incid
incomplet
kd
case
report
mild
symptom
lower
incid
cal
decreas
count
crp
platelet
togeth
increas
level
albumin
hemoglobin
compar
previou
case
suggest
advanc
diagnosi
incomplet
kd
evalu
presenc
anterior
uveiti
symptom
need
facilit
precis
identif
kd
patient
earli
ivig
treatment
minim
undiagnos
case
kd
highli
correl
increas
level
circul
inflammatori
immun
cell
infiltr
vascular
endotheli
cell
via
system
vascul
instead
contribut
singl
gene
multipl
gene
regul
inflammatori
cardiovascular
immun
respons
report
associ
pathogenesi
kd
kuo
et
al
studi
shown
kd
may
trigger
pathogen
microbi
viral
infect
lead
inflammatori
immun
respons
mediat
cell
ultim
destruct
vascular
endotheli
function
inflammatori
lesion
rowley
et
al
increas
incid
kd
recent
year
role
environment
factor
epidemiolog
kd
investig
rodo
et
al
suggest
northeastern
china
may
sourc
windborn
pathogen
kd
japan
rodo
et
al
studi
suggest
incid
kd
shanghai
china
increas
exposur
high
temperatur
independ
factor
b
tang
et
al
phytomedicin
air
pollut
zeft
et
al
taiwan
prolong
exposur
ozon
associ
higher
risk
kd
jung
et
al
recent
studi
also
depict
variou
dietari
factor
interlink
pathogenesi
kd
exampl
consumpt
soy
correl
higher
risk
kd
portman
et
al
pediatr
research
indic
intak
isoflavon
beyond
age
confer
matern
immun
instead
maternalfet
transmiss
isoflavon
correl
higher
incid
kd
asia
western
countri
rel
lower
soy
isoflavon
consumpt
portman
korea
report
postul
pathogenesi
kd
may
trigger
variant
normal
flora
genet
suscept
children
highli
relat
environment
factor
therefor
may
help
explain
epidemiolog
region
characterist
kd
lee
et
al
fact
clinic
symptom
fever
rash
conjunct
cervic
lymphadenopathi
epidemiolog
laboratori
characterist
kd
similar
classic
symptom
inflamm
ayusawa
et
al
ha
et
al
japan
lue
et
al
saguil
et
al
singh
et
al
therefor
kd
also
suggest
infecti
diseas
howev
still
definit
test
differenti
kd
diseas
scarlet
fever
juvenil
rheumatoid
arthriti
toxic
shock
syndrom
measl
caus
similar
symptom
maconochi
pilania
singh
rowley
shulman
therefor
physic
examin
test
urin
blood
test
electrocardiogram
echocardiogram
requir
diagnosi
kd
aha
publish
supplement
laboratori
criteria
level
crp
white
blood
cell
evolut
major
chang
diagnost
criteria
kd
refer
fever
last
week
therapeut
effect
antibiot
treatment
kawasaki
et
al
bilater
conjunctiv
hyperemia
lip
oral
chang
dri
lip
red
cleft
palat
tongu
nippl
bulg
diffus
oral
pharyng
mucosa
chang
extrem
earli
stage
diseas
red
palm
hand
hard
swell
hand
feet
membran
peel
metatars
toe
end
erythema
trunk
blister
scar
lymph
node
nonsuppur
grown
cm
diamet
modifi
fever
period
week
day
kim
specifi
number
kd
symptom
diagnos
least
item
confirm
supplementari
inform
echocardiogram
coronari
angiographi
confirm
diagnosi
coronari
aneurysm
coronari
arteri
dilat
major
symptom
diagnos
criteria
persist
fever
continu
day
prerequisit
kd
diagnosi
oloughlin
diagnosi
criteria
confirm
base
condit
possibl
diseas
need
exclud
confirm
diagnosi
persist
fever
observ
day
parallel
occurr
main
symptom
basi
diagnosi
kd
jane
et
al
patient
sustain
fever
less
day
also
diagnos
kd
typic
symptom
shown
diagnosi
accord
addit
refer
base
supplementari
symptom
manifest
emphas
import
clinic
diagnosi
incomplet
kd
main
symptom
complianc
rate
meet
full
kd
diagnost
requir
kd
also
diagnos
possibl
diseas
rule
patient
confirm
develop
coronari
aneurysm
coronari
arteri
dilat
diagnost
criteria
case
less
febril
day
earli
ivig
treatment
propos
case
febril
day
ayusawa
et
al
emphas
clinic
import
diagnosi
atyp
incomplet
suspici
case
order
princip
symptom
kd
rearrang
fever
ii
conjunctiv
congest
iii
chang
lip
oral
caviti
iv
rash
v
chang
extrem
vi
cervic
lymphadenopathi
standard
similar
kd
diagnost
standard
japan
diagnost
criteria
includ
continu
fever
day
possess
major
symptom
kd
possibl
get
diseas
ignor
burn
et
al
burn
et
al
diagnost
guid
fever
last
longer
day
essenti
diagnost
criterion
kd
main
symptom
appear
addit
fever
typic
kd
diagnos
even
fever
last
day
importantli
necessari
diagnosi
revis
diagnosi
criteria
incomplet
kd
emphas
also
diagnosi
procedur
evalu
incomplet
kd
suspect
case
propos
newburg
et
al
first
time
coronari
arteri
anomali
evalu
zvalu
ie
bodi
surfac
area
correct
coronari
lumen
diamet
saguil
et
al
patient
recoveri
fever
last
day
exclud
kd
diagnosi
diagnosi
process
incomplet
kd
simplifi
compar
version
ie
child
fever
day
fulfil
diagnost
criteria
fever
day
without
confirm
reason
also
diagnos
kd
support
clinic
laboratori
test
result
clinic
observ
propos
consider
diagnosi
kd
babi
less
month
prolong
fever
irrit
ii
longterm
fever
infant
unexplain
asept
mening
iii
infant
children
prolong
fever
unexplain
cultureneg
shock
iv
infant
children
prolong
fever
cervic
lymphaden
respons
antibiot
treatment
v
longterm
fever
infant
children
antibiot
treatment
toward
cellul
pharynx
propos
elev
ntermin
btype
brain
natriuret
peptid
ntbnp
suggest
cardiac
involv
use
kd
diagnosi
suggest
kd
patient
shock
prone
ivig
resist
coronari
arteri
complic
mitral
regurgit
prolong
myocardi
insuffici
clinic
manifest
tang
et
al
phytomedicin
hemoglobin
platelet
serum
albumin
alanin
aminotransferas
urin
white
blood
cell
diagnosi
incomplet
kd
laboratori
characterist
impli
infect
factor
close
relat
kd
saguil
et
al
howev
infecti
factor
kd
remain
unelucid
classic
method
microbi
cultur
microscopi
polymeras
chain
reaction
still
commonli
appli
diagnosi
kd
consist
season
cycl
infecti
diseas
epidemiolog
characterist
incid
kd
dispar
differ
season
ha
et
al
japan
lue
et
al
singh
et
al
accord
avail
data
largescal
nation
epidem
outbreak
kd
japan
respect
japan
studi
report
possibl
microb
microbederiv
substanc
may
caus
pathogenesi
kd
rickettsialik
agent
chlamydia
pneumonia
mycoplasma
pneumonia
rickettsia
organ
propionibacterium
acn
leptospira
spp
yersinia
pseudotuberculosi
retroviru
measl
chickenpox
human
herpesviru
cytomegaloviru
group
streptococcu
dengu
fever
viru
epsteinbarr
viru
coronaviru
parvoviru
bacillu
cereu
human
bocaviru
staphylococcu
staphylococc
streptococc
superantigen
rowley
et
al
recent
report
rhim
et
al
suggest
presum
etiolog
kd
may
associ
pathogen
acut
pyelonephr
exanthem
subitum
jungwoo
et
al
furthermor
jordan
et
al
report
kd
children
acquir
upper
respiratori
tract
infect
simultan
jordanvillega
et
al
therefor
report
suggest
prescript
ivig
therapi
suspect
kd
children
without
classic
clinic
symptom
record
respiratori
viral
infect
studi
suggest
human
adenoviru
hadv
one
pathogen
trigger
kd
fukuda
et
al
jaggi
et
al
exampl
fukuda
et
al
report
case
monozygot
twin
sequenti
diagnos
kd
conjunct
infect
fukuda
et
al
jaggi
et
al
report
case
kd
patient
diagnos
hadv
infect
quantit
polymeras
chain
reaction
jaggi
et
al
although
close
correl
variou
infecti
factor
kd
unlik
childhood
infecti
diseas
known
infecti
factor
vaccin
infecti
agent
contribut
pathogenesi
kd
remain
uncharacter
studi
requir
immunolog
abnorm
develop
coronari
arteri
lesion
involv
pathogenesi
kd
propos
lee
et
al
immunopathogenesi
kd
base
protein
homeostasi
system
control
pathogen
toxic
protein
spread
bind
endotheli
cell
coronari
arteri
involv
nonspecif
cell
nonspecif
antibodi
produc
variou
cytokin
contribut
endotheli
cell
injuri
innat
acquir
system
activ
pathogen
infect
clinic
laboratori
studi
found
occurr
kd
relat
activ
innat
immun
system
hara
et
al
broderick
et
al
report
case
kd
reoccurr
inflammatori
clinic
symptom
similar
recurr
fever
syndrom
exist
febril
diseas
due
dysregul
innat
immun
system
broderick
et
al
acquir
immun
system
cellmedi
immun
humor
immun
cellmedi
immun
activ
macrophag
cell
cluster
differenti
cd
releas
lymphokin
rowley
et
al
show
chronic
coronari
arter
kd
continu
long
onset
diseas
via
upregul
lymphocyt
type
interferon
gene
studi
report
increas
plasma
level
helper
cell
type
th
cytokin
interleukin
il
cytokin
acut
stage
kd
lee
et
al
suggest
cell
may
activ
simultan
acut
stage
kd
recent
year
research
focu
identifi
key
cytokin
respons
kd
tumor
necrosi
factor
tnf
report
play
tempor
role
acut
cardiac
inflamm
develop
coronari
vascul
respect
suggest
possibl
immunopathogenesi
kd
stock
et
al
recent
evid
suggest
kd
genet
diseas
accord
epidemiolog
survey
japan
incid
rate
kd
higher
children
sibl
parent
diagnos
kd
japan
besid
incid
kd
higher
asian
popul
especi
japanes
singh
et
al
suggest
pathogenesi
kd
caus
abnorm
immun
cascad
trigger
infect
may
correl
suscept
gene
account
monozygot
twin
diagnos
kd
genet
studi
suscept
gene
loci
kd
perform
use
candid
gene
genomewid
associ
method
gwa
onouchi
candid
gene
method
refer
select
potenti
site
known
gene
base
report
patholog
physiolog
process
specif
diseas
examin
correl
analysi
lv
et
al
previou
studi
candid
gene
kd
summar
tabl
c
lv
et
al
onouchi
onouchi
exampl
inositol
c
itpkc
one
isoenzym
inositol
phosphoryl
inositol
close
relat
pathogenesi
kd
onouchi
genomewid
associ
studi
gwa
also
known
whole
genom
associ
studi
refer
genomewid
highdens
genet
label
type
dna
sampl
health
control
diseas
case
group
whole
genomewid
comparison
small
genom
variat
singl
nucleotid
polymorph
snp
identifi
gene
may
contribut
develop
certain
diseas
kuo
et
al
lv
et
al
approach
use
identifi
snp
parkinson
diseas
witoelar
et
al
crohn
diseas
foo
et
al
diabet
bush
moor
heart
abnorm
bush
moor
consist
snp
within
itpkc
gene
highli
associ
develop
coronari
arteri
abnorm
kd
onouchi
howev
find
suggest
snp
itpkc
suscept
kd
may
vari
differ
ethnic
exampl
japan
snp
itpkc
associ
risk
coronari
arteri
abnorm
itpkc
snp
chines
associ
suscept
kd
european
popul
sever
gene
calciumcalmodulindepend
protein
kinas
type
ii
delta
chain
cub
sushi
multipl
domain
diacylglycerol
kinas
beta
ubiquitinprotein
ligas
nacetyl
alphalink
acid
dipeptidaselik
protein
phosphatas
regulatori
subunit
tcomplex
protein
subunit
alpha
zinc
finger
homeobox
melanoma
inhibitori
activityrasrel
gtpbind
protein
itpkc
burgner
et
al
khor
et
al
fc
fragment
immunoglobulin
g
lowaffin
ii
identifi
suscept
gene
kd
gwa
khor
et
al
research
also
suggest
suscept
gene
kd
correl
ethnic
exampl
snp
b
lymphocyt
kinas
nicotinamid
mononucleotid
adenylyltransferas
hla
class
histocompat
antigen
protein
nodlik
receptor
famili
pyrin
domain
contain
identifi
suscept
loci
pathogenesi
kd
korean
popul
kim
et
al
besid
snp
locat
crp
locu
found
highli
correl
crp
level
kd
patient
korea
kim
et
al
suscept
gene
locu
associ
kd
protein
pellino
homolog
kim
et
al
kim
et
al
coatom
subunit
beta
endoplasm
reticulum
aminopeptidas
immunoglobulin
heavychain
variabl
blk
human
leukocyt
antigen
hla
oh
et
al
b
tang
et
al
phytomedicin
kwon
et
al
tabl
identifi
asian
popul
onouchi
addit
genet
variant
also
depict
kd
patient
differ
nation
includ
chines
ji
et
al
european
korean
australian
new
zealand
khor
et
al
note
snp
within
gene
associ
develop
kd
taiwanes
children
kuo
et
al
although
literatur
report
possibl
genet
role
allel
pathophysiolog
kd
chines
children
studi
report
correl
snp
gene
incid
kd
patient
greek
origin
chatzikyriakid
et
al
qian
et
al
japan
number
cc
chemokin
ligand
gene
copi
highli
associ
occurr
kd
ivig
resist
correl
pathogenesi
kd
korean
patient
kim
et
al
suggest
suscept
gene
kd
may
specif
ethnic
accord
result
gwa
although
discrep
ethnic
welldefin
import
cal
ivig
resist
pathogenesi
kd
potassium
intermediatesmal
conduct
calciumactiv
channel
identifi
suscept
locu
develop
cal
kd
kim
et
al
addit
snp
also
one
factor
influenc
cur
effect
ivig
kd
ji
et
al
kuo
et
al
b
report
hypomethyl
correl
kd
resist
ivig
kuo
et
al
suggest
possibl
role
suscept
gene
develop
cal
ivig
resist
summar
integr
gene
respons
pathogenesi
kd
analyz
kdrelat
gene
report
literatur
among
kd
relat
pathway
kd
relat
gene
sort
interpret
function
annot
tool
bioinformat
resourc
databas
annot
visual
integr
discoveri
david
string
uniprot
discoveri
enrich
functionalrel
gene
group
huang
et
al
data
collect
david
function
annot
cluster
input
softwar
cytoscap
enrich
plugin
genet
network
summar
fig
accord
enrich
score
david
gene
includ
tolllik
receptor
caspas
casp
identifi
enrich
gene
kd
firstli
one
tolllik
receptor
level
found
upregul
peripher
blood
mononuclearmacrophag
cell
acut
kd
patient
compar
healthi
children
age
wang
et
al
togeth
elev
express
relat
molecul
myeloid
differenti
myeloid
differenti
factor
suggest
abnorm
activ
may
one
initi
factor
lead
immun
dysfunct
kd
patient
also
involv
activ
nuclear
factor
downstream
pathway
excess
product
proinflammatori
cytokin
wang
et
al
consist
bioinformat
data
report
associ
format
coronari
lesion
kd
patient
onouchi
et
al
besid
basic
role
trigger
apoptosi
interact
cell
receptor
correl
increas
transcript
activ
nuclear
factor
activ
tcell
signal
pathway
accompani
increas
level
cytokin
wu
et
al
fact
differ
protein
substrat
therefor
investig
immunoregulatori
role
pathogenesi
kd
highli
desir
literatur
also
show
express
level
significantli
higher
acut
kd
kd
coronari
arteri
lesion
group
suggest
possibl
immunolog
role
pathogenesi
kd
may
modul
receptor
transduct
pathway
collect
immun
function
relat
gene
hlag
crp
hlab
hlac
lta
hp
pafah
tumor
necrosi
factor
receptor
chemokin
cc
motif
ligand
matrix
program
cell
death
protein
hlag
human
leukocyt
antigen
g
hlab
human
leukocyt
antigen
b
hlac
human
leukocyt
antigen
c
cc
chemokin
receptor
type
cc
chemokin
receptor
type
interleukin
receptor
antagonist
interleukin
natur
resistanceassoci
macrophag
protein
lta
lymphotoxin
alpha
hp
haptoglobin
receptor
antagonist
udpglucuronosyltransferas
chemokin
receptor
matrix
heme
oxygenas
decycl
cluster
differenti
ligand
transform
growth
factor
beta
receptor
ii
protein
pellino
homolog
mother
decapentapleg
homolog
transform
growth
factorbeta
caspas
vegfa
v
ascular
endotheli
growth
factor
micb
mhc
class
polypeptiderel
sequenc
b
mica
mhc
class
polypeptiderel
sequenc
interleukin
interleukin
interleukin
interleukin
chemokin
cc
motif
ligand
cytotox
tlymphocyteassoci
protein
matrix
matrix
matrix
fgb
fibrinogen
beta
chain
cc
chemokin
receptor
type
prolinerich
coil
coil
inositol
receptor
type
collagen
type
xi
alpha
mannosebind
lectin
mif
macrophag
migrat
inhibitori
factor
tryptophan
hydroxylas
butyrophilinlik
protein
hlae
histocompat
antigen
alpha
chain
e
metalloproteinas
inhibitor
metalloproteinas
inhibitor
tnf
tumor
necrosi
factor
tumor
necrosi
matrix
ace
angiotensinconvert
enzym
kdr
kinas
insert
domain
receptor
angiotensin
ii
receptor
type
cluster
differenti
mthfr
methylen
tetrahydrofol
reductas
fc
region
receptor
iib
fc
region
receptor
iiia
fc
region
receptor
iiib
il
interleukin
vascular
endotheli
growth
factor
receptor
eno
endotheli
nitric
oxid
synthas
ino
induc
nitric
oxid
synthas
mbl
mannanbind
lectin
togeth
literatur
support
pathogen
role
differ
gene
kd
current
bioinformat
data
may
provid
use
inform
search
potenti
drug
target
gene
marker
regulatori
pathway
kd
provid
practition
research
field
clue
investig
etiolog
kd
remain
unelucid
therapi
type
kd
still
limit
combin
use
ivig
aa
differ
stage
kd
ivig
resist
refractori
kd
clinician
may
need
appli
second
dose
ivig
addit
treatment
design
antivascular
inflamm
newburg
et
al
report
depict
around
untreat
kd
patient
develop
cal
includ
coronari
arteri
dilat
aneurysm
fistula
format
kuo
et
al
howev
approxim
kd
patient
respond
ivig
treatment
eventu
led
higher
risk
cal
format
kd
shock
syndrom
burn
glode
gamezgonzalez
et
al
kuo
et
al
combin
therapi
ivig
aa
administ
reduc
incid
coronari
arteri
abnorm
antiinflammatori
antiplatelet
acut
phase
kd
adopt
standard
kd
therapi
mani
year
shulman
rowley
preval
coronari
abnorm
invers
relat
total
dose
ivig
independ
dose
aa
mgkg
per
day
japan
mgkg
per
day
north
america
acut
phase
terai
shulman
ivig
resist
defin
persist
fever
h
complet
ivig
treatment
singer
et
al
kd
patient
report
respons
treatment
ivig
highdos
aa
higher
risk
develop
coronari
heart
diseas
complic
singer
et
al
report
suggest
sever
biomark
genet
polymorph
appli
predict
resist
ivig
clusterin
ouyang
et
al
sato
et
al
wang
et
al
jia
et
al
forkhead
box
regulatori
cell
jia
et
al
laboratori
indic
also
import
predict
ivig
respons
exampl
age
sex
number
ill
day
platelet
count
erythrocyt
sediment
rate
aspart
aminotransferas
hemoglobin
concentr
crp
eosinophil
total
bilirubin
lactat
dehydrogenas
kuo
et
al
sleeper
et
al
cholesterol
hwang
et
al
serum
albumin
percentag
neutrophil
serum
sodium
level
moon
et
al
although
still
definit
treatment
kd
patient
ivig
resist
steroid
prednisolon
report
reduc
incid
coronari
abnorm
miyata
et
al
infliximab
son
et
al
methotrex
plasma
exchang
hokosaki
et
al
also
report
benefit
kd
patient
initi
ivig
treatment
failur
among
infliximab
report
process
good
adjuv
efficaci
kd
patient
ivig
resist
reduc
durat
fever
improv
ivig
reaction
rate
level
specif
inflammatori
marker
observ
consist
result
sever
independ
clinic
trial
differ
countri
exampl
japan
use
infliximab
correl
level
sever
transcript
associ
ivig
resist
factor
inflamm
signal
pathway
kd
peptidas
matrix
chemokin
ogihara
et
al
korea
retrospect
analysi
patient
refractori
kd
indic
infliximab
also
use
prevent
progress
cal
refractori
kd
song
et
al
possibl
advers
effect
result
standard
aa
treatment
ivig
therapi
risk
develop
rey
syndrom
rs
bioinformat
analysi
kdenrich
gene
summar
previou
literatur
report
gene
involv
pathogenesi
kd
graph
gener
cytoscap
softwar
data
collect
david
annot
tool
predict
enrich
kd
pathway
among
import
gene
predict
involv
kd
pathway
may
repres
potenti
gene
marker
diagnosi
treatment
kd
gene
linkag
higher
import
modul
kd
kd
patient
belay
et
al
remington
et
al
rs
occur
treatment
fever
drug
contain
aa
usual
preced
viral
infect
especi
influenza
chickenpox
children
teenag
lead
possibl
lethal
side
effect
toxic
encephalopathi
liver
dysfunct
chornomydz
et
al
surveil
rs
first
start
us
earli
led
restrict
use
aa
children
nowaday
chapman
arnold
besid
accord
aha
diagnost
guidelin
kd
kd
patient
prescrib
high
dose
aa
treatment
possibl
risk
get
rs
therefor
replac
aa
anoth
antiplatelet
drug
recommend
mccrindl
et
al
japan
nejihashi
et
al
taiwan
wei
et
al
hong
kong
su
et
al
unit
state
belay
et
al
although
occasion
rs
case
report
find
altern
antiinflammatori
drug
herbal
compound
replac
aa
desir
fact
mani
studi
propos
use
tradit
chines
medicin
tcm
natur
product
supplementari
therapi
kd
tabl
e
exampl
resveratrol
viti
vinifera
l
fruit
possess
antiinflammatori
effect
human
coronari
arteri
endotheli
cell
via
decreas
level
express
intercellular
adhes
induc
nitric
oxid
synthas
autophagi
besid
low
dose
resveratrol
could
protect
experiment
induc
rs
partial
via
inhibit
oxid
stress
restor
complex
activ
abdin
sarhan
base
observ
natur
product
may
work
possibl
supplement
appli
aa
infant
young
children
reduc
risk
rs
side
effect
hand
triptolid
tripterygium
wilfordii
hookf
root
could
reduc
express
intercellular
adhes
endotheli
cell
increas
rate
apoptosi
inflammatori
cell
mous
model
kd
yan
zou
suggest
triptolid
may
altern
adjuv
antiinflammatori
agent
treat
kd
accord
result
independ
clinic
studi
conduct
mainland
china
treatment
ligustrazin
alkaloid
extract
rhizom
ligusticum
striatum
dc
combin
standard
kd
therapi
use
aa
ivig
antiblood
clot
medicin
dipyridamol
show
significantli
better
improv
reliev
symptom
increas
bodi
temperatur
coronari
arteri
dilat
compar
treatment
group
western
medicin
alon
luo
neng
et
al
tanshinon
iia
natur
compound
extract
salvia
miltiorrhiza
bung
root
also
appli
combin
aa
ivig
treat
kd
clinic
studi
confirm
cotreat
tanshinon
iia
ivig
aa
shorten
time
fever
reduc
level
crp
facilit
faster
recoveri
coronari
arteri
damag
compar
standard
ivig
aa
treatment
alon
zhang
et
al
addit
singl
herbal
chemic
report
also
suggest
use
tradit
herbal
decoct
formul
treatment
kd
exampl
qing
liang
xue
decoct
compos
salvia
miltiorrhiza
bung
lonicera
japonica
thunb
flower
forsythia
suspens
thunberg
vahl
fruit
anemarrhena
asphodeloid
bung
rhizom
prescrib
ivig
aa
dipyridamol
reduc
platelet
count
decreas
serum
level
improv
hypercoagul
state
kd
patient
chen
et
al
suggest
effect
use
tcm
allevi
inflamm
kd
patient
similarli
tcm
salvia
miltiorrhiza
bung
lonicera
japonica
thunb
forsythia
suspens
thunberg
vahl
cortex
moutan
radici
root
bark
paeonia
suffruticosa
andr
help
resum
normal
blood
platelet
level
suppress
activ
platelet
reduc
incid
cal
kd
patient
ruosha
shujuan
cohort
studi
case
kd
result
indic
combin
treatment
tcm
contain
yinqiaosan
qing
ying
tang
radix
ophiopogon
soup
ivig
aa
could
help
resum
normal
level
sever
physiolog
marker
kd
patient
qin
et
al
addit
bai
hu
decoct
exert
antipyret
antiinflammatori
effect
reduc
coronari
arteri
antiinflammatori
regul
immun
system
wang
feng
b
tang
et
al
phytomedicin
inflamm
patient
kd
wang
report
indic
case
kd
treat
jie
du
hua
yu
decoct
combin
ivig
show
shorter
symptom
durat
compar
group
treat
combin
antiinfect
agent
cephalosporin
penicillin
aa
without
ivig
clinic
paramet
crp
erythrocyt
sediment
rate
recoveri
rate
coronari
arteri
diamet
expans
tcm
treatment
group
ivig
improv
better
antiinfect
agent
aa
combin
treatment
group
without
ivig
liu
clinic
studi
use
herbal
decoct
addit
standard
aa
ivig
treatment
confirm
effect
tcm
adjuv
therapi
kd
exampl
cotreat
herbal
decoct
contain
gypsum
fibrosum
salvia
miltiorrhiza
bung
lonicera
japonica
thunb
forsythia
suspens
thunberg
vahl
aa
ivig
attenu
symptom
level
white
blood
cell
platelet
crp
esr
shorter
durat
control
group
aa
ivig
treatment
baoshen
linlin
et
al
linlin
et
al
hand
tcm
also
play
import
immunomodulatori
role
acut
phase
kd
exampl
yinqiaosan
qingwen
baidu
yin
bamboo
leav
gypsum
soup
could
reduc
inflammatori
respons
acut
phase
respons
prevent
thrombosi
regul
bodi
immun
system
cohort
studi
patient
kd
wang
feng
base
clinic
observ
tcm
may
act
effect
adjunct
treatment
kd
via
shorten
diseas
durat
reduc
symptom
diseas
less
advers
side
effect
liu
wang
feng
wang
base
observ
select
herbal
chemic
possess
potent
antiinflammatori
immunoregulatori
effect
herebi
propos
potenti
remedi
treatment
kd
fig
b
exampl
interlink
genet
suscept
kd
tradit
clinic
applic
modern
pharmacolog
action
select
natur
product
list
potenti
herbal
candid
treat
kd
propos
shown
tabl
f
target
potenti
kd
gene
sever
potenti
effect
singl
compon
deriv
natur
plant
suggest
exampl
kaempferol
deriv
kaempferia
galanga
l
may
work
novel
therapeut
agent
kd
via
decreas
express
level
bronchoalveolar
lavag
fluid
cell
medeiro
et
al
quercetin
deriv
fagopyrum
tataricum
l
gaertn
oak
speci
decreas
level
cervic
carcinoma
cell
facilit
cytotox
lymphocyt
respons
hill
et
al
similarli
emodin
deriv
rheum
rhabarbarum
l
rhamnu
dahurica
pall
bark
reynoutria
japonica
houtt
rhizom
root
may
also
use
treat
kd
via
abil
decreas
level
inhibit
activ
wu
et
al
target
gene
sever
natur
compound
suggest
futur
investig
exampl
cryptotanshinon
deriv
salvia
miltiorrhiza
bung
decreas
express
cell
stimul
lp
suggest
cryptotanshinon
may
possess
antiinflammatori
properti
via
inhibit
signal
pathway
decreas
express
zerumbon
deriv
zingib
zerumbet
l
smith
rhizom
monocycl
sesquiterpenoid
b
tang
et
al
phytomedicin
reduc
level
proinflammatori
cytokin
decreas
upregul
protein
level
possess
antiinflammatori
activ
leng
et
al
show
astragalosid
iv
deriv
astragalu
propinquu
schischkin
root
decreas
express
vivo
vitro
significantli
improv
aortic
endotheli
function
leng
et
al
suggest
potenti
use
herbal
chemic
treat
kd
although
region
season
variat
epidemiolog
kd
gener
trend
incid
rate
kd
increas
worldwid
increas
number
case
kd
clinic
diagnost
guidelin
constantli
updat
classifi
differ
type
kd
although
literatur
attribut
pathogenesi
kd
differ
factor
region
ethnic
dispar
dietari
environment
factor
infecti
agent
immuoregulatori
inflammatori
respons
genet
suscept
still
lack
conclus
integr
summari
confirm
etiolog
kd
fact
kd
classifi
selflimit
acut
childhood
diseas
nowaday
consid
one
possibl
caus
reason
develop
coronari
arteri
diseas
adult
therefor
earli
diagnosi
use
highend
technolog
identif
specif
clinic
kd
marker
deserv
elucid
kd
commonli
consid
immun
diseas
howev
via
candid
gene
genomewid
associ
studi
kd
variou
genet
factor
relat
immun
inflammatori
system
final
contribut
diseas
suscept
discov
bioinformat
analysi
current
studi
identifi
enrich
gene
includ
highli
correl
pathophysiolog
kd
present
combin
ivig
aa
standard
therapi
adopt
clinic
practic
worldwid
numer
kd
case
report
ivig
resist
besid
possibl
risk
get
rs
prescript
aa
children
also
worth
identif
adjuv
therapi
kd
review
use
herbal
therapi
adjuv
therapi
kd
therefor
propos
herbal
decoct
suggest
prescript
due
tradit
usag
treat
kd
herbal
chemic
target
immun
inflammatori
system
also
suscept
gene
kd
also
recommend
pharmacolog
clinic
evalu
advanc
technolog
modern
pharmacolog
research
anticip
novel
therapeut
remedi
target
specif
clinic
marker
kd
could
develop
accur
diagnosi
treatment
diseas
inhibit
inflamm
target
transduc
activ
signal
pathway
li
et
al
danshenyin
salvia
miltiorrhiza
bung
santalum
album
l
lignum
amomum
villosum
lour
fruit
reduc
level
inflammatori
factor
scaveng
free
radic
enhanc
antioxid
defens
enzym
yan
et
al
b
tang
et
al
phytomedicin
author
declar
conflict
interest
